AbstractBackgroundCell-based quadrivalent-inactivated influenza vaccine has been shown to have higher vaccine effectiveness than traditional egg-based quadrivalent-inactivated influenza vaccine. This is observed despite similar levels of serum hemagglutinin antibodies induced by each vaccine.MethodsIn this study...
Human-papillomavirus-vaccine-recombinant-quadrivalProduct-launchesdoi:10.2165/00128413-200715750-00057NAAdis InternationalInpharma Weekly
Sanofi Pasteur expects that two-thirds of all adults 65 years old and older who will get a flu shot in the United States will receive Fluzone high-dose vaccine.Flublok quadrivalent vaccine is indicated for adults 18 years old and older, and is proven to help prevent more cases of flu in...
The efficacy of the trivalent and quadrivalent formulations are related because both are made using the same process and have overlapping compositions The only vaccine that uses the flu virus's genetic makeup to guarantee an exact match to WHO- and FDA-selected strains ...
Sanofi’s vaccines portfolio already includes the four-in-one influenza vaccine Fluzone Quadrivalent, which the FDA approved in June 2013. But the addition of Flublok brings a vaccine that can be used by those with egg allergies and has shorter production timelines than tradition vaccines. Manon ...
In a randomized controlled trial, Flublok (quadrivalent) provided 30% (95% CI: 10-47) better protection against influenza due to any PCR-confirmed circulating strains vs a standard-dose quadrivalent inactivated influenza vaccine in adults 50 years of age and older.1,3 ...